Literature DB >> 27280308

Induced radioactivity of a GSO scintillator by secondary fragments in carbon ion therapy and its effects on in-beam OpenPET imaging.

Yoshiyuki Hirano1, Munetaka Nitta, Fumihiko Nishikido, Eiji Yoshida, Naoko Inadama, Taiga Yamaya.   

Abstract

The accumulation of induced radioactivity within in-beam PET scanner scintillators is of concern for its long-term clinical usage in particle therapy. To estimate the effects on OpenPET which we are developing for in-beam PET based on GSOZ (Zi doped Gd2SiO5), we measured the induced radioactivity of GSO activated by secondary fragments in a water phantom irradiation by a (12)C beam with an energy of 290 MeV u(-1). Radioisotopes of Na, Ce, Eu, Gd, Nd, Pm and Tb including positron emitters were observed in the gamma ray spectra of the activated GSO with a high purity Ge detector and their absolute radioactivities were calculated. We used the Monte Carlo simulation platform, Geant4 in which the observed radioactivity was assigned to the scintillators of a precisely reproduced OpenPET and the single and coincidence rates immediately after one treatment and after one-year usage were estimated for the most severe conditions. Comparing the highest coincidence rate originating from the activated scintillators (background) and the expected coincidence rate from an imaging object (signal), we determined the expected signal-to-noise ratio to be more than 7 within 3 min and more than 10 within 1 min from the scan start time. We concluded the effects of scintillator activation and their accumulation on the OpenPET imaging were small and clinical long-term usage of the OpenPET was feasible.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27280308     DOI: 10.1088/0031-9155/61/13/4870

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  3 in total

1.  Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with 64Cu-labeled cetuximab to treat early- and late-phase peritoneal dissemination in human gastrointestinal cancer xenografts.

Authors:  Yukie Yoshii; Mitsuyoshi Yoshimoto; Hiroki Matsumoto; Hideaki Tashima; Yuma Iwao; Hiroyuki Takuwa; Eiji Yoshida; Hidekatsu Wakizaka; Taiga Yamaya; Ming-Rong Zhang; Aya Sugyo; Sayaka Hanadate; Atsushi B Tsuji; Tatsuya Higashi
Journal:  Oncotarget       Date:  2018-06-22

2.  Integrated 64Cu therapy for the peritoneal dissemination of gastrointestinal cancer.

Authors:  Hiroaki Kurihara
Journal:  Oncotarget       Date:  2018-07-27

3.  Immuno-OpenPET: a novel approach for early diagnosis and image-guided surgery for small resectable pancreatic cancer.

Authors:  Yukie Yoshii; Hideaki Tashima; Yuma Iwao; Eiji Yoshida; Hidekatsu Wakizaka; Go Akamatsu; Taiga Yamaya; Hiroki Matsumoto; Mitsuyoshi Yoshimoto; Chika Igarashi; Fukiko Hihara; Tomoko Tachibana; Ming-Rong Zhang; Kotaro Nagatsu; Aya Sugyo; Atsushi B Tsuji; Tatsuya Higashi
Journal:  Sci Rep       Date:  2020-03-10       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.